AIC
ASND icon

AWM Investment Company’s Ascendis Pharma A/S ASND Stock Holding History

AWM Investment Company’s Portfolio ASND Stock Details ASND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-78,540
Closed -$1.39M – 96
2015
Q3 		$1.39M Buy
+78,540
New +$1.53M 0.27% 82

Other funds holding ASND

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
RIM
RS Investment Management San Francisco, California $9.73B AUM 3.24% 1-Year Est. Return
VMI
VHCP Management II New York $379M AUM 421.62% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

AWM Investment Company's ASND Position: Q4 2015 in Review

AWM Investment Company sold out of Ascendis Pharma A/S (ASND) in Q4 2015, closing a stake of 78,540 shares — an estimated $1.39M sold.

AWM Investment Company first reported a position in ASND in Q3 2015 and held it in 1 quarter. The position peaked at $1.39M in Q3 2015. 25 funds tracked by Wall St. Rank hold ASND as of Q4 2015.

  • AWM Investment Company reported no remaining Ascendis Pharma A/S position as of Q4 2015 after selling out during the quarter.
  • AWM Investment Company sold 78,540 Ascendis Pharma A/S shares in Q4 2015, an estimated $1.39M.
  • AWM Investment Company first reported a position in Ascendis Pharma A/S in Q3 2015 and held it in 1 quarter.
  • AWM Investment Company's Ascendis Pharma A/S position peaked at $1.39M in Q3 2015.
  • 25 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q4 2015.

Based on AWM Investment Company's 13F filing for Q4 2015, filed 8 Feb 2016.